Maria E. Arango

2.6k citations

20 papers · 2.1k indexed · 2 hit papers · h-index 15

Impact in

Oncology top 2%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Hepatology top 5%
- Liver physiology and pathology

Papers in ⓘ

Cell Biology 7
- Proteoglycans and glycosaminoglycans research 4
- Microtubule and mitosis dynamics 3
Oncology 10
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 3

Co-authors: James G. Christensen (6 shared papers)Gerrit Los (6 shared papers)Kermit L. Carraway (8 shared papers)Helen Y. Zou (3 shared papers)Qiuhua Li (3 shared papers)Joseph H. Lee (3 shared papers)Shinji Yamazaki (3 shared papers)Gordon Alton (2 shared papers)
Journals: Molecular Cancer Therapeutics (4 papers)Clinical Cancer Research (3 papers)Oncogene (2 papers)Cancer Research (2 papers)Journal of Nuclear Medicine (1 paper)
Partner nations: United States United Kingdom Australia

In The Last Decade

Maria E. Arango

19 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma 2007 · 513 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Molecular Cancer Therapeutics
2007 Cancer Research

Peers

Countries citing papers authored by Maria E. Arango

Since Specialization

Citations

This map shows the geographic impact of Maria E. Arango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria E. Arango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria E. Arango more than expected).

Fields of papers citing papers by Maria E. Arango

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria E. Arango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria E. Arango. The network helps show where Maria E. Arango may publish in the future.

Co-authors

The 25 scholars most cited alongside Maria E. Arango, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maria E. Arango Line = papers co-authored together Maria E. Arango links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Cancer Research ·Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, Scott R. McDonnell, Shinji Yamazaki, Tatiana Koudriakova, Gordon Alton, Jingrong Jean Cui, Pei-Pei Kung, Mitchell D. Nambu, Gerrit Los, Steven L. Bender, Barbara Mroczkowski, James G. Christensen Hit paper breakdown →	2007	593
2	Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma Molecular Cancer Therapeutics ·James G. Christensen, Helen Y. Zou, Maria E. Arango, Qiuhua Li, Joseph H. Lee, Scott R. McDonnell, Shinji Yamazaki, Gordon Alton, Barbara Mroczkowski, Gerrit Los Hit paper breakdown →	2007	513
3	Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1 Molecular Cancer Therapeutics ·Alessandra Blasina, Jill Hallin, Enhong Chen, Maria E. Arango, Eugenia Kraynov, James Register, Stephan K. Grant, Sacha Ninkovic, Ping Chen, Tim Nichols, Patrick M. O’Connor, Kenna Anderes	2008	171
4	Rat Muc4 (sialomucin complex) reduces binding of anti‐ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance International Journal of Cancer ·Shari A. Price‐Schiavi, Scott Jepson, Peter Li, Maria E. Arango, Philip S. Rudland, Xuhui Lee, Kermit L. Carraway	2002	157
5	Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways Oncogene ·Scott Jepson, Masanobu Komatsu, Bushra Haq, Maria E. Arango, Daming Huang, Coralie A. Carothers Carraway, Kermit L. Carraway	2002	116
6	Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor Oncogene ·Masanobu Komatsu, Scott Jepson, Maria E. Arango, Coralie A. Carothers Carraway, Kermit L. Carraway	2001	106
7	Muc4/sialomucin complex, the intramembrane Er6B2 ligand, in cancer and epithelia: To protect and to survive Progress in nucleic acid research and molecular biology ·Kermit L. Carraway, Aymee Perez, Nebila Idris, Scott Jepson, Maria E. Arango, Masanobu Komatsu, Bushra Haq, Shari A. Price‐Schiavi, Jin Zhang, C A Carraway	2002	94
8	PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity Clinical Cancer Research ·Cathy C. Zhang, Zhengming Yan, Qin Zhang, Kyle Kuszpit, Kenneth Zasadny, Ming Qiu, Cory L. Painter, Anthony Wong, Eugenia Kraynov, Maria E. Arango, Pramod P. Mehta, Ian Popoff, Gerald F. Casperson, Gerrit Los, Steve Bender, Kenna Anderes, James G. Christensen, Todd VanArsdale	2010	58
9	Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor Molecular Cancer Therapeutics ·Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, Kristina Burgess, Ming Qiu, Lars D. Engstrom, Shinji Yamazaki, Max Parker, Sergei Timofeevski, Jingrong Jean Cui, Michele McTigue, Gerrit Los, Steven L. Bender, Tod Smeal, James G. Christensen	2012	57
10	PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts Clinical Cancer Research ·Cathy Zhang, Zhengming Yan, Cory L. Painter, Qin Zhang, Enhong Chen, Maria E. Arango, Kyle Kuszpit, Kenneth Zasadny, Max Hallin, Jill Hallin, Anthony Wong, Dana Buckman, Guizhen Sun, Ming Qiu, Kenna Anderes, James G. Christensen	2009	45
11	Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland. PubMed ·Maria E. Arango, Peter Li, Masanobu Komatsu, Carlos Montes, Coralie A. Carothers Carraway, Kermit L. Carraway	2001	42
12	Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis Biochemical Journal ·Masanobu Komatsu, Maria E. Arango, Kermit L. Carraway	2002	41
13	Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models Clinical Cancer Research ·Cathy Zhang, Zhengming Yan, Maria E. Arango, Cory L. Painter, Kenna Anderes	2008	32
14	Differential ¹⁸F-FDG and 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models Journal of Nuclear Medicine ·Carleen Cullinane, Donna S. Dorow, Susan Jackson, Benjamin Solomon, Ekaterina Bogatyreva, David Binns, Richard Young, Maria E. Arango, James G. Christensen, Grant A. McArthur, Rodney J. Hicks	2011	29
15	An ErbB2-Muc4 complex in rat ocular surface epithelia Current Eye Research ·Jeremy S. Swan, Maria E. Arango, Coralie A. Carothers Carraway, Kermit L. Carraway	2002	18
16	Expression and localization of immunoreactive-sialomucin complex (Muc4) in salivary glands Tissue and Cell ·Peter Li, Maria E. Arango, R.E. Perez, Celso A. Reis, Esteban Bonfante, Donald T. Weed, Kermit L. Carraway	2001	14
17	AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity Cancer Research ·Cathy C. Zhang, Susan E. Kephart, Indrawan McAlpine, Jim Nonomiya, Joseph R. Higgins, Maria E. Arango, Zhengming Yan, Daniel Knighton, Rose Ann Ferre, Jayashree Tikhe, Gennady M. Verkhivker, Meirong Xu, William H. Romines, Cindy Palmer, Julie Park, Siegfried Reich, Wes Chong, Lin Li, Gerrit Los, Cristina Lewis	2005	8
18	Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy Molecular Cancer Therapeutics ·Cathy Zhang, Karen Lundgren, Zhengming Yan, Maria E. Arango, Sharon Price, Andrea B. Huber, Joseph R. Higgins, Gabriel E. Troche, Judith Skaptason, Tatiana Koudriakova, Jim Nonomiya, Michelle Yang, P M O'Connor, Steve Bender, Gerrit Los, Cristina Lewis, Bart Jessen	2008	8
19	Using Behavior Science to Maximize Human Performance Juan Carlos López, Monica Alexandra Lopez, W Friedl, Maria E. Arango, Monica Cristina Duran, Hamed Al Shibani, David B. Allison, Pierre Bordage	2021	2
20	753 Aquatic Therapy Improves Functional Outcomes in a Pediatric Burn Patient Journal of Burn Care & Research ·Maria E. Arango, Carl I. Schulman	2023	0

About Maria E. Arango

Maria E. Arango is a scholar working on Cell Biology, Oncology, Immunology and Allergy, Hepatology and Immunology, having authored 20 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers), Galectins and Cancer Biology (3 papers), Cancer-related Molecular Pathways (3 papers), HER2/EGFR in Cancer Research (3 papers), Microtubule and mitosis dynamics (3 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (236 citations), Pulmonary and Respiratory Medicine (695 citations), Molecular Biology (1.2k citations) and Cancer Research (211 citations). Maria E. Arango has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include James G. Christensen, Gerrit Los, Kermit L. Carraway, Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Shinji Yamazaki, Gordon Alton, Barbara Mroczkowski and Scott R. McDonnell. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, Oncogene, Cancer Research and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact